{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T18:28:53Z","timestamp":1761762533056},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2001,4,1]]},"DOI":"10.1038\/sj.gt.3301432","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T16:58:48Z","timestamp":1031158728000},"page":"557-567","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Genetic prodrug activation therapy (GPAT) in two rat prostate models generates an immune bystander effect and can be monitored by magnetic resonance techniques"],"prefix":"10.1038","volume":"8","author":[{"given":"J D","family":"Eaton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M J A","family":"Perry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S M","family":"Todryk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R A","family":"Mazucco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R S","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J R","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A G","family":"Dalgleish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2001,4,23]]},"reference":[{"key":"BF3301432_CR1","first-page":"455","volume":"26","author":"D Hrouda","year":"1999","unstructured":"Hrouda D, Perry M, Dalgleish AG . Gene therapy for prostate cancer Semin Oncol 1999 26: 455\u2013471","journal-title":"Semin Oncol"},{"key":"BF3301432_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nm0598supp-525","volume":"4","author":"DM Pardoll","year":"1998","unstructured":"Pardoll DM . Cancer vaccines Nat Med 1998 4: 525\u2013531","journal-title":"Nat Med"},{"key":"BF3301432_CR3","first-page":"5160","volume":"59","author":"JW Simons","year":"1999","unstructured":"Simons JW et al. Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte\u2013macrophage colony-stimulating factor using ex vivo gene transfer Cancer Res 1999 59: 5160\u20135168","journal-title":"Cancer Res"},{"key":"BF3301432_CR4","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/(SICI)1097-0045(19970901)32:4<272::AID-PROS7>3.0.CO;2-L","volume":"32","author":"BA Tjoa","year":"1997","unstructured":"Tjoa BA et al. Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides Prostate 1997 32: 272\u2013278","journal-title":"Prostate"},{"key":"BF3301432_CR5","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/0959-8049(94)E0159-2","volume":"30A","author":"S Vesalainen","year":"1994","unstructured":"Vesalainen S, Lipponen P, Talja M, Syrjanen K . Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants oflong-term prognosis in prostatic adenocarcinoma Eur J Cancer 1994 30A: 1797\u20131803","journal-title":"Eur J Cancer"},{"key":"BF3301432_CR6","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1046\/j.1464-410X.1998.00803.x","volume":"82","author":"D Hrouda","year":"1998","unstructured":"Hrouda D et al. Immunotherapy of advanced prostate cancer: a phase I\/II trial using Mycobacterium vaccae (SRL172) Br J Urol 1998 82: 568\u2013573","journal-title":"Br J Urol"},{"key":"BF3301432_CR7","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1023\/A:1008307821189","volume":"10","author":"A Maraveyas","year":"1999","unstructured":"Maraveyas A et al. Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: correlation with induction of increased levels of intracellular interleukin-2 in peripheral blood lymphocytes Ann Oncol 1999 10: 817\u2013824","journal-title":"Ann Oncol"},{"key":"BF3301432_CR8","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1054\/bjoc.1999.1034","volume":"82","author":"AG Heriot","year":"2000","unstructured":"Heriot AG et al. Reduction in cytokine production in colorectal cancer patients: association with stage and reversal by resection Br J Cancer 2000 82: 1009\u20131012","journal-title":"Br J Cancer"},{"key":"BF3301432_CR9","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0090-4295(99)80301-X","volume":"46","author":"RA Blades","year":"1995","unstructured":"Blades RA et al. Loss of HLA class I expression in prostate cancer: implications for immunotherapy Urology 1995 46: 681\u2013687","journal-title":"Urology"},{"key":"BF3301432_CR10","first-page":"5274","volume":"53","author":"SM Freeman","year":"1993","unstructured":"Freeman SM et al. The \u2018bystander effect\u2019: tumor regression when a fraction of the tumor mass is genetically modified Cancer Res 1993 53: 5274\u20135283","journal-title":"Cancer Res"},{"key":"BF3301432_CR11","first-page":"6228","volume":"54","author":"RG Vile","year":"1994","unstructured":"Vile RG et al. Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component Cancer Res 1994 54: 6228\u20136234","journal-title":"Cancer Res"},{"key":"BF3301432_CR12","first-page":"829","volume":"24","author":"R Ramesh","year":"1996","unstructured":"Ramesh R et al. In vivo analysis of the \u2018bystander effect\u2019: a cytokine cascade Exp Hematol 1996 24: 829\u2013838","journal-title":"Exp Hematol"},{"key":"BF3301432_CR13","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1089\/hum.1997.8.5-597","volume":"8","author":"RD Alvarez","year":"1997","unstructured":"Alvarez RD, Curiel DT . A phase I study of recombinant adenovirus vector-mediated intraperitoneal delivery of herpes simplex virus thymidine kinase (HSV-TK) gene and intravenous ganciclovir for previously treated ovarian and extraovarian cancer patients Hum Gene Ther 1997 8: 597\u2013613","journal-title":"Hum Gene Ther"},{"key":"BF3301432_CR14","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1089\/hum.1998.9.7-1083","volume":"9","author":"DH Sterman","year":"1998","unstructured":"Sterman DH et al. Adenovirus-mediated herpes simplex virus thymidine kinase\/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma Hum Gene Ther 1998 9: 1083\u20131092","journal-title":"Hum Gene Ther"},{"key":"BF3301432_CR15","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1089\/10430349950018229","volume":"10","author":"JR Herman","year":"1999","unstructured":"Herman JR et al. In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial Hum Gene Ther 1999 10: 1239\u20131249","journal-title":"Hum Gene Ther"},{"key":"BF3301432_CR16","first-page":"1627","volume":"2","author":"CA Pettaway","year":"1996","unstructured":"Pettaway CA et al. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice Clin Cancer Res 1996 2: 1627\u20131636","journal-title":"Clin Cancer Res"},{"issue":"Suppl. 1","key":"BF3301432_CR17","first-page":"86","volume":"80","author":"M Stubbs","year":"1999","unstructured":"Stubbs M, Griffiths JR . Monitoring cancer by magnetic resonance Br J Cancer 1999 80 (Suppl. 1): 86\u201394","journal-title":"Br J Cancer"},{"key":"BF3301432_CR18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/BF01114871","volume":"1","author":"JR Griffiths","year":"1981","unstructured":"Griffiths JR et al. 31P-NMR investigation of solid tumours in the living rat Biosci Reps 1981 1: 319\u2013325","journal-title":"Biosci Reps"},{"key":"BF3301432_CR19","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/S0140-6736(83)92375-9","volume":"i","author":"JR Griffiths","year":"1983","unstructured":"Griffiths JR et al. 31P-NMR studies of a human tumour in situ Lancet 1983 i: 1435\u20131436","journal-title":"Lancet"},{"key":"BF3301432_CR20","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/nbm.1940060602","volume":"6","author":"JD deCertaines","year":"1993","unstructured":"deCertaines JD et al. In vivo\u200231P MRS of experimental tumours NMR Biomed 1993 6: 345\u2013365","journal-title":"NMR Biomed"},{"key":"BF3301432_CR21","first-page":"651","volume":"1","author":"BD Ross","year":"1995","unstructured":"Ross BD, Kim B, Davidson B . Assessment of ganciclovir toxicity to experimental intracranial gliomas following recombinant adenoviral mediated transfer of the herpes simplex virus thymidine kinase gene by magnetic resonance imaging and proton magnetic resonance spectroscopy Clin Cancer Res 1995 1: 651\u2013657.","journal-title":"Clin Cancer Res"},{"key":"BF3301432_CR22","first-page":"66","volume":"2","author":"M Izquierdo","year":"1995","unstructured":"Izquierdo M et al. Long term rat survival after malignant brain-tumor regression by retroviral gene-therapy Gene Therapy 1995 2: 66\u201369","journal-title":"Gene Therapy"},{"key":"BF3301432_CR23","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1089\/hum.1996.7.15-1847","volume":"7","author":"H Namba","year":"1996","unstructured":"Namba H et al. Evaluation of the bystander effect in experimental brain tumors bearing herpes simplex virus-thymidine kinase gene by serial magnetic resonance imaging Hum Gene Ther 1996 7: 1847\u20131852","journal-title":"Hum Gene Ther"},{"key":"BF3301432_CR24","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/(SICI)1099-1492(199612)9:8<364::AID-NBM436>3.0.CO;2-W","volume":"9","author":"LD Stegman","year":"1996","unstructured":"Stegman LD, Ben-Yoseph O, Freyer JP, Ross BD . In vivo\u200231P MRS evaluation of ganciclovir toxicity in C6 gliomas stably expressing the herpes simplex thymidine kinase gene NMR Biomed 1996 9: 364\u2013368","journal-title":"NMR Biomed"},{"key":"BF3301432_CR25","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/15279","volume":"5","author":"JM Hakum\u00e4ki","year":"1999","unstructured":"Hakum\u00e4ki JM et al. 1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: implications for the in vivo detection of apoptosis Nat. Med 1999 5: 1323\u20131327","journal-title":"Nat. Med"},{"key":"BF3301432_CR26","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nm0598-581","volume":"4","author":"A Melcher","year":"1998","unstructured":"Melcher A et al. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression Nat. Med 1998 4: 581\u2013587","journal-title":"Nat. Med"},{"key":"BF3301432_CR27","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1046\/j.1464-410X.1998.00881.x","volume":"82","author":"D Hrouda","year":"1998","unstructured":"Hrouda D et al. Mycobacterium vaccae (SRL172): a potential immunological adjuvant evaluated in rat prostate cancer Br J Urol 1998 82: 870\u2013876","journal-title":"Br J Urol"},{"key":"BF3301432_CR28","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1046\/j.1464-410x.2000.00887.x","volume":"86","author":"D Hrouda","year":"2000","unstructured":"Hrouda D et al. Allogeneic whole tumour cell vaccination in the rat model of prostate cancer Br J Urd 2000 86: 742\u2013748","journal-title":"Br J Urd"},{"key":"BF3301432_CR29","first-page":"1760","volume":"54","author":"J Vieweg","year":"1994","unstructured":"Vieweg J et al. Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines Cancer Res 1994 54: 1760\u20131765","journal-title":"Cancer Res"},{"key":"BF3301432_CR30","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S0022-5347(17)35032-2","volume":"151","author":"MG Sanda","year":"1994","unstructured":"Sanda MG et al. Demonstration of a rational strategy for human prostate cancer gene therapy J Urol 1994 151: 622\u2013628","journal-title":"J Urol"},{"key":"BF3301432_CR31","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1089\/hum.1996.7.4-515","volume":"7","author":"JA Eastham","year":"1996","unstructured":"Eastham JA et al. Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models Hum Gene Ther 1996 7: 515\u2013523","journal-title":"Hum Gene Ther"},{"key":"BF3301432_CR32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/(SICI)1097-0215(19970410)71:2<267::AID-IJC23>3.0.CO;2-D","volume":"71","author":"RG Vile","year":"1997","unstructured":"Vile RG et al. Generation of an anti-tumour immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoural cytokine expression Int J Cancer 1997 71: 267\u2013274","journal-title":"Int J Cancer"},{"key":"BF3301432_CR33","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1042\/bst0250717","volume":"25","author":"RG Vile","year":"1997","unstructured":"Vile RG, Diaz RM, Castleden S, Chong H . Targeted gene therapy for cancer: herpes simplex virus thymidine kinase gene-mediated cell killing leads to anti-tumour immunity that can be augmented by co-expression of cytokines in the tumour cells Biochem Soc Trans 1997 25: 717\u2013722","journal-title":"Biochem Soc Trans"},{"key":"BF3301432_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/nbm.1940020302","volume":"2","author":"RG Steen","year":"1989","unstructured":"Steen RG et al. 31P NMR spectroscopic and near infrared spectrophotometric studies of effects of anesthetics on in vivo RIF-1 tumors. Relationship to tumor radiosensitivity NMR Biomed 1989 2: 87\u201392","journal-title":"NMR Biomed"},{"key":"BF3301432_CR35","first-page":"89","volume":"48","author":"LM Rodriguez","year":"1988","unstructured":"Rodriguez LM et al. 31P nuclear magnetic resonance spectroscopy studies of the response of rat mammary tumours to endocrine therapy Cancer Res 1988 48: 89\u201393","journal-title":"Cancer Res"},{"key":"BF3301432_CR36","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/nbm.1940050518","volume":"5","author":"WG Negendank","year":"1992","unstructured":"Negendank WG . Studies on human tumours by MRS: a review NMR Biomed 1992 5: 303\u2013324","journal-title":"NMR Biomed"},{"key":"BF3301432_CR37","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/nbm.1940050506","volume":"5","author":"J Ruiz-Cabello","year":"1992","unstructured":"Ruiz-Cabello J, Cohen JS . Phospholipid metabolites as indicators of cancer cell function NMR Biomed 1992 5: 226\u2013233","journal-title":"NMR Biomed"},{"key":"BF3301432_CR38","first-page":"283","volume":"66","author":"RJ Ordidge","year":"1986","unstructured":"Ordidge RJ, Connelly A, Lohman JAB . Image-selected in vivo spectroscopy (ISIS). A new technique for spatially selective NMR spectroscopy J Magn Reson 1986 66: 283\u2013294","journal-title":"J Magn Reson"},{"key":"BF3301432_CR39","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/mrm.1910060111","volume":"6","author":"JWC van der Veen","year":"1988","unstructured":"van der Veen JWC, de Beer R, Luyten PR, Van Ormondt D . Accurate quantification of in vivo P-31 NMR signals using the variable projection method and prior knowledge Magn Res Med 1988 6: 92\u201398","journal-title":"Magn Res Med"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3301432.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3301432","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3301432.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T01:33:46Z","timestamp":1648604026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3301432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4,1]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2001,4,1]]}},"alternative-id":["BF3301432"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3301432","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,4,1]]},"assertion":[{"value":"30 May 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2001","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}